The grey market premium (GMP) for the issue stood at 36% ahead of the opening, implying an unofficial market price of around Rs 283 against...

There are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...

Nvidia and Boeing stocks crashed on May 15, 2026, falling 3.83% and 2.86% respectively, even as Trump announced major China deals. Beijing ...

Lime, the electric bike and scooter company, has filed for a U.S. initial public offering. The firm reported a significant increase in year...

Reconstruction of global supply chains, strategic competition between major economies, emergence of digital technologies like artificial in...

US stock market today: Dow Jones jumps 650 points, Nasdaq surges as AMD stock explodes 19%, oil crashes, and AI optimism reshapes Wall Stre...

Markets closed lower amid global headwinds and geopolitical worries. Several companies like Paytm, Bajaj Auto, and L&T are in focus due to ...

Biocon's chairperson, Kiran Mazumdar-Shaw, has named her niece, Claire Mazumdar, as her successor, sparking a more than 1% jump in the comp...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

UAE's exit from OPEC+ coordination has little short-term oil impact. Geopolitical issues dominate. Markets have rallied, but easy gains are...

Kailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....

Biotechnology firm Transgene Biotek today said that its board of directors has decided to delist its shares from Indian stock exchanges.

Biotechnology firm Biocon today posted a growth rate of 24.55 per cent in net profit at Rs 100.75 crore for the third qaurter ended Decembe...

Foreign brokerage Citigroup has assigned a ‘sell’ rating on integrated biotechnology company Biocon citing higher vulnerability of the comp...

Vincent Aita of Kilkenny Capital Management says he picks biotechnology stocks on their potential as takeover targets.